Movement Disorders

Iris Y. Kim, Éilis J. O'Reilly, Katherine C. Hughes, Xiang Gao, Michael A. Schwarzschild, Marjorie L. McCullough, Marian T. Hannan, Rebecca A. Betensky, Alberto Ascherio January 16, 2018

ABSTRACT

Background: Caffeine intake has been inversely associated with Parkinson’s disease (PD) risk. This relationship may be modified by polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2), but the results of previous studies have been inconsistent.

Read More...
James H. Bower, Brandon R. Grossardt, Walter A. Rocca, Rodolfo Savica December 26, 2017

ABSTRACT

Background: The prevalence of patients with PD taking antipsychotics is unknown.

Objective: To measure the prevalence of patients with PD taking antipsychotics.

Methods: We used the medical records-linkage system of the Rochester Epidemiology Project to study the use of antipsychotic medication in all persons with Parkinson disease in Olmsted County, Minnesota on 1 January 2006.

Read More...

Andoird App
Loading...